Posts by Ting Sung
The Target Product Profile: A Foundation for Patient Impact & Commercial Success
By: Alyssa Trigger, senior principal The target product profile (TPP) has long been a quintessential planning tool in therapeutic product development, but too often it becomes a “check the box” activity and fails to serve its main purpose – to be the strategic ‘north star’ that defines the requirements to deliver a meaningful benefit to…
Read MoreNational Rare Disease Day – February 28, 2023
National Rare Disease Day is observed on February 29th, the rarest day of the year, or on this year on February 28th. This year’s theme is focused on health equity. As rare diseases affect small numbers of patients, understanding the diversity of patients and how it affects presentation, diagnosis, and treatment is crucial for addressing…
Read MoreCan Digital Technologies Improve Oncology Care?
By: Dennis Chang, Ph.D., managing director, Tracy McCarty, senior principal, Daniyal Tariq, senior associate, and Natalie Thovmasian, Ph.D., senior principal Digital technologies are becoming more prevalent across the healthcare field, and new applications in oncology have begun to emerge. These applications span a wide range, operating at the level of populations or for individuals, and…
Read MoreChina’s Oncology Pipeline: 2022 Recap and Future Outlook
By: Dennis Chang, Ph.D., managing director and Letao Fan, Ph.D., senior associate In 2022, China was at the center of a significant amount of international news coverage, most of which focused on the ongoing COVID-19 pandemic, including widespread lockdowns. These reports painted a picture of disruption to society and the economy. However, China’s oncology pipeline…
Read MoreHighlights of ESMO Congress 2022
By: Dennis Chang, Ph.D., Alissa Clear Ph.D., Krisstel Gomez, Andrew Hayden, Claudia Lanauze-Torres, Ph.D., and Natalie Thovmasian, Ph.D. There were over 3000+ abstracts at this year’s conference. In the following article, our Clarion oncology team shares key highlights from ESMO 2022. DETERMINING THE RIGHT PLACE FOR IMMUNOTHERAPY IN EARLY-STAGE DISEASE Many IO experts have long…
Read MoreHealthcare disparities among rural populations
Understanding how geographic differences affect patient experiences in rare disorders.
Read More4th Annual Emerging Frontiers in Oncology Highlights
“New Modalities at the Crossroads,” explores how we can potentially draw lessons from history to help us strike the right balance in which bets to place in oncology innovation.
Read More